Written answers
Thursday, 23 March 2017
Department of Health
Medicinal Products Reimbursement
Charlie McConalogue (Donegal, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
141. To ask the Minister for Health the status of the ongoing negotiations between the HSE and manufacturers regarding the drug Savitex; if he will ensure that the drug will be made available to persons; and if he will make a statement on the matter. [14590/17]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on the reimbursement of approved products in Ireland and suppliers of such products must apply to the HSE for reimbursement approval.
I am advised that, following receipt of an application from the supplier for the inclusion of Sativex on the High Tech Scheme, the HSE assessed the medicine in line with their statutory responsibility. The HSE issued the manufacturers with notice of its intention not to reimburse. It is open to the supplier to make a new application for this product, in the context of the previous findings.
No comments